SEC Form SC 13G/A filed by Doximity Inc. (Amendment)

SEC Form SC 13G/A filed by Doximity Inc. (Amendment)

Recent Analyst Ratings for $DOCS

$DOCS Market Insights

$DOCS SEC Filings

$DOCS Large Ownership Changes

$DOCS Leadership Updates

$DOCS Analyst Ratings

$DOCS Press Releases

$DOCS Insider Trading

$DOCS Financials

Recent Analyst Ratings for
$DOCS

$DOCS
Market Insights

$DOCS
SEC Filings

$DOCS
Large Ownership Changes

$DOCS
Leadership Updates

$DOCS
Analyst Ratings

$DOCS
Press Releases

$DOCS
Insider Trading

$DOCS
Financials

Chat with this insight

Live Market Insights

Doximity shares are trading lower after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $27 to $19.

Cracking The Code: Understanding Analyst Reviews For Doximity

Wells Fargo Downgrades Doximity to Underweight, Lowers Price Target to $19

SEC Form 10-Q filed by Doximity Inc.

Doximity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Doximity Inc.

SEC Form SC 13G filed by Doximity Inc.

SEC Form SC 13G filed by Doximity Inc.

Live Leadership Updates

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Doximity Appoints Phoebe Yang to Its Board of Directors

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Fastest customizable press release news feed in the world

Goldman initiated coverage on Doximity with a new price target

Doximity upgraded by Morgan Stanley with a new price target

Doximity downgraded by Canaccord Genuity with a new price target

Doximity Announces Fiscal 2025 Second Quarter Financial Results

Doximity to Present at the Jefferies London Healthcare Conference

Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Financial Officer Bryson Anna covered exercise/tax liability with 5,120 shares, decreasing direct ownership by 2% to 299,386 units (SEC Form 4)

Chief Executive Officer Tangney Jeffrey covered exercise/tax liability with 21,087 shares, decreasing direct ownership by 0.83% to 2,530,497 units (SEC Form 4)

Chief Financial Officer Bryson Anna converted options into 100,000 shares and sold $5,842,248 worth of shares (100,000 units at $58.42) (SEC Form 4)

Live finance-specific insights

Doximity Announces Fiscal 2025 Second Quarter Financial Results

Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024

Doximity Announces Fiscal 2025 First Quarter Financial Results

2/14/24 2:47:49 PM ET

$DOCS

EDP Services

Technology

Get the next $DOCS alert in real time by email

SC 13G/A 1 d786222dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)*

Doximity, Inc.

(Name of Issuer)

CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE

(Title of Class of Securities)

26622P107

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 26622P107		SCHEDULE 13G		Page 2 of 10 Pages

(1)	Represents 14,462,728 shares of Class B Common Stock held directly by Emergence Capital Partners II, L.P.

(2)

Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer’s certificate of incorporation.

(3)	The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

(4)	Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


CUSIP No. 26622P107		SCHEDULE 13G		Page 3 of 10 Pages

(1)	Represents 775,000 shares of Class A Common Stock held directly by Emergence Capital Opportunity I, L.P.

(2)	The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.


CUSIP No. 26622P107		SCHEDULE 13G		Page 4 of 10 Pages

(1)	Represents 14,462,728 shares of Class B Common Stock held directly by Emergence Capital Partners II, L.P. (“ECP II”). Emergence Equity Partners II, L.P. is the sole general partner of ECP II, and may be deemed to beneficially own the shares of stock held directly by ECP II.

(2)

(3)	The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

(4)	Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


CUSIP No. 26622P107		SCHEDULE 13G		Page 5 of 10 Pages

(1)	Represents 775,000 shares of Class A Common Stock held directly by Emergence Capital Opportunity I, L.P. (“ECO I”). Emergence Equity Partners VI, L.P., is the sole general partner of ECO I, and may be deemed to beneficially own the shares of stock held directly by ECO I.

(2)	The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.


CUSIP No. 26622P107		SCHEDULE 13G		Page 6 of 10 Pages

(1)	Represents 14,462,728 shares of Class B Common Stock held directly by ECP II and 775,000 shares of Class A Common Stock held directly by ECO I.

(2)

(3)	The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

(4)	Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


CUSIP No. 26622P107		SCHEDULE 13G		Page 7 of 10 Pages


Item 1.		Issuer

	(a)	Name of Issuer:

		Doximity, Inc. (the “Issuer”)

	(b)	Address of Issuer’s Principal Executive Offices:

		500 3^rd Street Suite 510 San Francisco, California 94107

Item 2.		Filing Person

	(a) – (c)	Name of Persons Filing; Address; Citizenship:

			(i) Emergence Capital Partners II, L.P., a Delaware limited partnership; (ii) Emergence Capital Opportunity I, L.P., a Delaware limited partnership; (iii) Emergence Equity Partners II, L.P., a Delaware limited partnership; (iv) Emergence Equity Partners VI, L.P., a Delaware limited partnership; and (v) Emergence GP Partners, LLC, a Delaware limited liability company.

		The address of the principal business office of each of the reporting persons are 5 Pier, Ste. 102, San Francisco, CA 94111.

	(d)	Title of Class of Securities:

		Class A Common Stock, $0.001 par value per share, (the “Common Stock”)

	(e)	CUSIP Number:

		26622P107

Item 3.	If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

	(a)	☐	Broker or dealer registered under Section 15 of the Act;

	(b)	☐	Bank as defined in Section 3(a)(6) of the Act;

	(c)	☐	Insurance company as defined in Section 3(a)(19) of the Act;

	(d)	☐	Investment company registered under Section 8 of the Investment Company Act of 1940;

	(e)	☐	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

	(f)	☐	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

	(g)	☐	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

	(h)	☐	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

	(i)	☐	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

	(j)	☐	A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

	(k)	☐	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

		If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:


CUSIP No. 26622P107		SCHEDULE 13G		Page 8 of 10 Pages


Item 4.	Ownership.

	(a) and (b)	Amount beneficially owned:

		(i)	Emergence Capital Partners II, L.P. (“ECP II”) directly owns 14,462,728 shares of Class B Common Stock, which, when such shares are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 10.9% of the outstanding shares of Class A Common Stock.

		(ii)	Emergence Capital Opportunity I, L.P. (“ECO I”) directly owns 775,000 shares of Class A Common Stock, which, represents approximately 0.7% of the outstanding shares of Class A Common Stock.

		(iii)	Emergence Equity Partners II, L.P. (“EEP II”) is the sole general partner of ECP II, and may be deemed to beneficially own 14,462,728 shares of Class B Common Stock, which, when such shares are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 10.9% of the outstanding shares of Class A Common Stock.

		(iv)	Emergence Equity Partners VI, L.P. (“EEP VI”) is the sole general partner of ECO I, and may be deemed to beneficially own 775,000 shares of Class A Common Stock, which, represents approximately 0.7% of the outstanding shares of Class A Common Stock.

		(v)	Emergence GP Partners, LLC (“EGP”) is the sole general partner of EEP II and the sole general partner of EEP VI, and may be deemed to beneficially own 14,462,728 shares of Class B Common Stock and 775,000 shares of Class A Common Stock held directly by ECP II and ECO I, respectively, which, when such shares of Class B Common Stock are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 11.5% of the outstanding shares of Class A Common Stock.

			The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

	(c)	Number of shares as to which such person has:


	Number of Shares of Class A Common Stock
Reporting Person	(i)		(ii)		(II)		(iv)
Emergence Capital Partners II, L.P.		14,462,728		-0-		14,462,728		-0-
Emergence Capital Opportunity I, L.P.		775,000		-0-		775,000		-0-
Emergence Equity Partners II, L.P.		14,462,728		-0-		14,462,728		-0-
Emergence Equity Partners VI, L.P.		775,000		-0-		775,000		-0-
Emergence GP Partners, LLC		15,237,728		-0-		15,237,728		-0-

(i) Sole power to vote or direct the vote

(ii) Shared power to vote or to direct the vote

(iii) Sole power to dispose or to direct the disposition of

(iv) Shared power to dispose or to direct the disposition of


		The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

Item 5.		Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☐

Item 6.		Ownership of More than Five Percent on Behalf of Another Person. Not applicable.


CUSIP No. 26622P107		SCHEDULE 13G		Page 9 of 10 Pages


Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Item 8.		Identification and Classification of Members of the Group. Not applicable.

Item 9.		Notice of Dissolution of Group. Not applicable.

Item 10.		Certification . Not applicable.


CUSIP No. 26622P107		SCHEDULE 13G		Page 10 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2024


EMERGENCE CAPITAL PARTNERS II, L.P.

By: Emergence Equity Partners II, L.P., its sole general partner
By: Emergence GP Partners, LLC, its sole general partner

By:		/s/ David Singer
		Name: David Singer
		Title: Attorney-in-Fact

EMERGENCE CAPITAL OPPORTUNITY I, L.P.

By: Emergence Equity Partners VI, L.P., its sole general partner
By: Emergence GP Partners, LLC, its sole general partner

By:		/s/ David Singer
		Name: David Singer
		Title: Attorney-in-Fact

EMERGENCE EQUITY PARTNERS II, L.P.

By: Emergence GP Partners, LLC, its sole general partner

By:		/s/ David Singer
		Name: David Singer
		Title: Attorney-in-Fact

EMERGENCE EQUITY PARTNERS VI, L.P.

By: Emergence GP Partners, LLC, its sole general partner

By:		/s/ David Singer
		Name: David Singer
		Title: Attorney-in-Fact

EMERGENCE GP PARTNERS, LLC

By:		/s/ David Singer
		Name: David Singer
		Title: Attorney-in-Fact

Get the next $DOCS alert in real time by email

Date	Price Target	Rating	Analyst
11/15/2024	$58.00	Neutral	Goldman
11/14/2024	$33.00 → $53.00	Underweight → Equal-Weight	Morgan Stanley
11/13/2024	$40.00 → $60.00	Buy → Hold	Canaccord Genuity
11/8/2024	$19.00 → $41.00	Underweight → Equal Weight	Wells Fargo
11/8/2024	$70.00	Sector Weight → Overweight	KeyBanc Capital Markets
10/15/2024	$35.00 → $52.00	Equal Weight → Overweight	Barclays
8/9/2024	$38.00	Hold → Buy	Needham
7/18/2024	$27.00 → $19.00	Equal Weight → Underweight	Wells Fargo

NAMES OF REPORTING PERSONS

Emergence Capital Partners II, L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐ (b) ☒

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware